Akebia Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Akebia Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2013 to Q3 2024.
  • Akebia Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $27.1M, a 603% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $27.1M +$23.3M +603% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $17.8M +$14.4M +431% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $11.8M +$6.56M +125% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $12.4M +$7.05M +131% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $3.86M -$22.1M -85.1% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $3.35M -$31.6M -90.4% Jun 30, 2023 10-Q 2023-08-28
Q1 2023 $5.24M -$34.2M -86.7% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $5.37M -$45M -89.3% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $25.9M -$43.7M -62.7% Sep 30, 2022 10-K/A 2023-08-28
Q2 2022 $35M -$32.5M -48.2% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $39.4M -$218K -0.55% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $50.4M +$12.4M +32.8% Dec 31, 2021 10-K/A 2023-08-28
Q3 2021 $69.6M +$25.4M +57.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $67.5M +$20.2M +42.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $39.6M -$32.3M -44.9% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $38M -$38M -50% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $44.2M -$53.7M -54.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $47.3M -$53.3M -53% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $71.9M -$56.2M -43.9% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $76M -$61.1M -44.6% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $97.9M +$95.4M +3829% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $101M +$97.9M +3711% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $128M +$126M +6247% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $137M +$135M +5926% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $2.49M +$1.21M +93.6% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $2.64M +$1.14M +76% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $2.02M +$719K +55.4% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $2.27M +$991K +77.2% Dec 31, 2017 10-K 2019-03-26
Q3 2017 $1.29M +$4K +0.31% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $1.5M +$218K +17% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $1.3M +$18K +1.41% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $1.28M +$2K +0.16% Dec 31, 2016 10-K 2018-03-12
Q3 2016 $1.28M +$978K +321% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $1.28M +$976K +320% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $1.28M +$976K +320% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $1.28M +$976K +320% Dec 31, 2015 10-K 2017-03-06
Q3 2015 $305K +$180K +144% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $305K +$180K +143% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $305K +$180K +143% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $305K +$180K +144% Dec 31, 2014 10-K 2016-03-14
Q3 2014 $125K Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $125K Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $125K Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $125K Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.